BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Jonathan Douxfils; Hélène Haguet; Christian Chatelain; Carlos Graux; Jean-Michel Dogne

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Jonathan Douxfils, Hélène Haguet, Christian Chatelain, Carlos Graux, Jean-Michel Dogne

Résultats de recherche: Contribution dans un livre/un catalogue/un rapport/dans les actes d'une conférence › Article dans les actes d'une conférence/un colloque

langue originale	Anglais
titre	Blood - 2015 ASH Annual Meeting Abstracts
Pages	2785 - 2785
Nombre de pages	1
Volume	126
Etat de la publication	E-pub ahead of print - 4 déc. 2015
Evénement	57th ASH Annual Meeting and Exposition - Orlando, États-Unis Durée: 4 déc. 2015 → 8 déc. 2015

Une conférence

Une conférence	57th ASH Annual Meeting and Exposition
Pays	États-Unis
La ville	Orlando
période	4/12/15 → 8/12/15

1 Actif

The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors
Douxfils, J., MULLIER, F. & Haguet, H.
1/09/15 → …
Projet: Recherche

Contient cette citation

@inproceedings{3e2384e458c8474e83adf2374fdad801,

title = "BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival",

author = "Jonathan Douxfils and H{\'e}l{\`e}ne Haguet and Christian Chatelain and Carlos Graux and Jean-Michel Dogne",

year = "2015",

month = dec,

day = "4",

language = "English",

volume = "126",

pages = "2785 -- 2785",

booktitle = "Blood - 2015 ASH Annual Meeting Abstracts",

note = "null ; Conference date: 04-12-2015 Through 08-12-2015",

}

Douxfils, J , Haguet, H , Chatelain, C , Graux, C & Dogne, J-M 2015, BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival. Dans Blood - 2015 ASH Annual Meeting Abstracts. VOL. 126, p. 2785 - 2785, 57th ASH Annual Meeting and Exposition, Orlando, États-Unis, 4/12/15.

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival. / Douxfils, Jonathan ; Haguet, Hélène ; Chatelain, Christian ; Graux, Carlos ; Dogne, Jean-Michel.

Blood - 2015 ASH Annual Meeting Abstracts. Vol 126 2015. p. 2785 - 2785.

Résultats de recherche: Contribution dans un livre/un catalogue/un rapport/dans les actes d'une conférence › Article dans les actes d'une conférence/un colloque

TY - GEN

T1 - BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

AU - Douxfils, Jonathan

AU - Haguet, Hélène

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Dogne, Jean-Michel

PY - 2015/12/4

Y1 - 2015/12/4

M3 - Conference contribution

VL - 126

SP - 2785

EP - 2785

BT - Blood - 2015 ASH Annual Meeting Abstracts

Y2 - 4 December 2015 through 8 December 2015

ER -

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Une conférence

The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

Contient cette citation